JIUYUAN GENE

2566
4.2600.00% ( 0.000 )
Delay Closed: Nov 16, 16:08:00

Overview

JIUYUAN GENE (2566)

Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, manufacturing, and commercialization of...

Open
4.275
High
4.275
Low
4.250
Prev. Close
4.260
Volume
5.20K
Turnover
22.14K
Avg Price
4.258
Bid/Ask Ratio
50.00%
Amplitude
0.59%
52wk High
10.774
Volume Ratio
0.32
Turnover Ratio
0.00%
52wk Low
4.200
HK Mkt Cap
1.01B
Market CapHKD
1.01B
P/ETTM
6.27
P/EDynamic
4.79
P/EStatic
--
EPSTTM
0.679
EPSDynamic
0.889
EPSStatic
--
BVPS
8.21
P/B
0.52
HK Shares
236.52M
Dividend YieldTTM
1.57%
DividendTTM
0.067
Shares
236.52M
Min lot size
200
Currency
HKD

Daily Events

  1. Jul, 2

    Hangzhou Jiuyuan Genetic Biopharmaceutical staged a sharp rally in the afternoon session, closing at HKD 6.62 for a 12.20% gain vs. the prior close of HKD 5.90. The stock formed a deep intraday reversal, hitting a low of HKD 5.84 before surging to an intraday high of HKD 6.95, yielding an 18.81% daily range. The company has repeatedly filed HKEX next-day disclosure returns on share repurchases (e.g., average prices from HKD 5.72 to HKD 5.83) and cancellations, signaling strong management confidence amid a previously announced up-to-CNY 100 million buyback plan. On fundamentals, Q4 2025 net profit jumped 51.62% YoY to HKD 26.8 million, while operating profit surged 60.98% YoY, building on the recovery trend seen in Q3. The stock trades at a PE of 10.4x and a PB of 0.87x. However, the price still sits 59.36% below its 52-week high (HKD 16.29) and 13.01% lower YTD, suggesting the rally owes more to buyback momentum than a re-rating.

News